USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Fully equipped labs with 75-member team set-up and made operational in <100 days
Ministry of Ayush is leading a topic group on traditional medicine as part of Focus Group on Artificial Intelligence for Health (FG-AI4H)
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
From cancer research to diagnostic solutions
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Subscribe To Our Newsletter & Stay Updated